Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation
Elizabeth M. Kline, Madelyn C. Houser, Mary K. Herrick, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 25-36
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 789
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Ai Huey Tan, Shen‐Yang Lim, Anthony E. Lang
Nature Reviews Neurology (2022) Vol. 18, Iss. 8, pp. 476-495
Closed Access | Times Cited: 209
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 115-128
Closed Access | Times Cited: 160
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 18
Preventing Parkinson’s Disease: An Environmental Agenda
Briana R. De Miranda, Samuel M. Goldman, Gary W. Miller, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 45-68
Open Access | Times Cited: 66
Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease
Zhu Liu, Qingli Fan, Shizheng Wu, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 64
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease
Daniele Bottigliengo, Luisa Foco, Philip Seibler, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3444-3453
Open Access | Times Cited: 62
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Alysa Kasen, Christina Houck, Amanda R. Burmeister, et al.
Neurobiology of Disease (2022) Vol. 166, pp. 105654-105654
Open Access | Times Cited: 50
Synucleins: New Data on Misfolding, Aggregation and Role in Diseases
Andrei Surguchov, Alexei Surguchev
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3241-3241
Open Access | Times Cited: 46
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
The Endotoxin Hypothesis of Parkinson's Disease
Guy C. Brown, Marta Camacho, Caroline H. Williams‐Gray
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1143-1155
Open Access | Times Cited: 30
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease from Mice to Human
Martina Montanari, Paola Imbriani, Paola Bonsi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1560-1560
Open Access | Times Cited: 30
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 29
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 28
α-Synuclein Induces Neuroinflammation Injury through the IL6ST-AS/STAT3/HIF-1α Axis
Danyu Lin, Han Zhang, Jieli Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1436-1436
Open Access | Times Cited: 25
A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis
Jake Boles, Maeve E. Krueger, Janna Jernigan, et al.
Brain Behavior and Immunity (2024) Vol. 117, pp. 473-492
Open Access | Times Cited: 11
Multi‐omic landscaping of human midbrains identifies disease‐relevant molecular targets and pathways in advanced‐stage Parkinson's disease
Lucas Caldi Gomes, Ana Galhoz, Gaurav Jain, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Adithya Gopinath, Phillip Mackie, Basil Hashimi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Using the Biopsychosocial Model to Guide Patient-Centered Neurological Treatments
Aneeta Saxena, Sara Paredes-Echeverri, R. Michaelis, et al.
Seminars in Neurology (2022) Vol. 42, Iss. 02, pp. 080-087
Closed Access | Times Cited: 29
The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
Zongran Liu, Yang Z. Huang, Xuejing Wang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 19
Towards improved screening of toxins for Parkinson’s risk
Ling Shan, Harm J. Heusinkveld, Kimberly C. Paul, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
An update on the emerging neuroprotective potential of Moringa oleifera and its prospects in complimentary neurotherapy
Gauri Srivastava, Deepak Ganjewala
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100532-100532
Open Access | Times Cited: 8
Phosphorylation of AQP4 by LRRK2 R1441G impairs glymphatic clearance of IFNγ and aggravates dopaminergic neurodegeneration
Heng Huang, Lishan Lin, Tengteng Wu, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
Mengyuan Guo, Xunming Ji, Jia Liu
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 24
Nootkatone alleviates rotenone‐induced Parkinson's disease symptoms through activation of the PI3K/Akt signaling pathway
Zi-Wei Yao, Jiayuan Li, Li-hua Bian, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 11, pp. 4183-4200
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top